Radnostix Acquires Lucerno Dynamics Assets Expanding Radiopharma Medical Device Portfolio

Radnostix (OTCQB: INIS) announced the successful closing of its acquisition of key assets from Lucerno Dynamics, LLC. The transaction is a positive step toward expanding its radioisotope production and nuclear medicine capabilities, though the available excerpt provides no financial impact details (e.g., purchase price or milestone economics).

Analysis

Radnostix (OTCQB: INIS) announced the successful closing of its acquisition of key assets from Lucerno Dynamics, LLC. The transaction is a positive step toward expanding its radioisotope production and nuclear medicine capabilities, though the available excerpt provides no financial impact details (e.g., purchase price or milestone economics).